Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2018

Study Completion Date

May 31, 2019

Conditions
Coronary Restenosis
Interventions
DEVICE

Drug Eluting Balloon Catheters(RESTORE DEB)

DEVICE

Drug Eluting Balloon Catheters(SeQuent® Please)

Trial Locations (14)

30051

Tianjin Chest Hospital, Tianjin

100020

Beijing Chaoyang Hospital, Beijing

100029

Beijing Anzhen Hospital,Capital Medical University, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

100853

Chinese PLA General Hospital, Beijing

130021

The First Hospital of Jilin University, Changchun

130041

The Second Hospital of Jilin University, Changchun

163000

Daqing Oilfield General Hospital, Daqing

210006

Nanjing First Hospital, Nanjing

310009

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

310016

Sir Run Run Shaw Hospital School of medicine, Zhejiang University, Hangzhou

710038

Tangdu Hospital, Xi'an

730000

The First Hospital of Lanzhou University, Lanzhou

061001

Cangzhou Central Hospital, Cangzhou

All Listed Sponsors
collaborator

R&G Pharma Studies Co.,Ltd.

INDUSTRY

lead

ZhuHai Cardionovum Medical Device Co., Ltd.

INDUSTRY

NCT02944890 - Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis | Biotech Hunter | Biotech Hunter